SNOA insider transactions
Sonoma Pharmaceuticals Inc. (SNOA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
SNOA insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Sonoma Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.
- Philippe WeigerstorferDirector
- Amy Moss TromblyChief Executive Officer
- John MclaughlinDirector
- Vanessa JacobyDirector, since January 2026
- Jerome J DvonchChief Financial Officer, since April 2023
- Poggetto John DalController, since July 2023
- Jay E BirnbaumDirector
- Bruce ThorntonExecutive VP and COO
- Chad Norman WhiteOfficer, since October 2022
Recent Form 3, 4, and 5 filings for SNOA
- SEC Form 4 filed by Director Weigerstorfer Philippe4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Trombly Amy Moss4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Director Mclaughlin John4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Director Jacoby Vanessa4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Dvonch Jerome J4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Controller Dal Poggetto John4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 3 filed by new insider Jacoby Vanessa3 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Director Weigerstorfer Philippe4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Trombly Amy Moss4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Director Mclaughlin John4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Dvonch Jerome J4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Controller Dal Poggetto John4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Director Birnbaum Jay E4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Executive VP and COO Thornton Bruce4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Controller Dal Poggetto John4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Dvonch Jerome J4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Trombly Amy Moss4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Director Birnbaum Jay E4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Controller Dal Poggetto John4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Director Weigerstorfer Philippe4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Director Mclaughlin John4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Executive VP & COO Thornton Bruce4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Dvonch Jerome J4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Trombly Amy Moss4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- Executive Vice President Thornton Bruce was granted 53,586 shares, increasing direct ownership by 53% to 154,411 units (SEC Form 4)4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- Chief Executive Officer Trombly Amy Moss was granted 53,586 shares, increasing direct ownership by 54% to 153,586 units (SEC Form 4)4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- Chief Financial Officer Dvonch Jerome J was granted 53,586 shares, increasing direct ownership by 173% to 84,595 units (SEC Form 4)4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- Controller Dal Poggetto John was granted 15,000 shares (SEC Form 4)4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Trombly Amy Moss4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Thornton Bruce4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Dal Poggetto John4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Dvonch Jerome J4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 3 filed by new insider Dal Poggetto John3 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Thornton Bruce4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Trombly Amy Moss4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 3: New insider Dvonch Jerome J claimed ownership of 31,009 shares3 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by White Chad Norman4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Weigerstorfer Philippe4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Trombly Amy Moss4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Thornton Bruce4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Mclaughlin John4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Birnbaum Jay E4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 3 filed by new insider White Chad Norman3 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Weigerstorfer Philippe4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Trombly Amy Moss4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Thornton Bruce4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Mclaughlin John4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Dvonch Jerome J4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)
- SEC Form 4 filed by Birnbaum Jay E4 - Sonoma Pharmaceuticals, Inc. (0001367083) (Issuer)